| Issue Date | Title | Author(s) |
| 2017 | Cost-effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMOD | Huber, M; Präger, M; Coyle, K; Coyle, D; Lester-George, A; Trapero-Bertran, M; Nemeth, B; Cheung, KL; Stark, R; Vogl, M; Pokhrel, S; Leidl, R |
| 2018 | Cannabis for pediatric epilepsy: Protocol for a living systematic review | Elliott, J; DeJean, D; Clifford, T; Coyle, D; Potter, B; Skidmore, B; Alexander, C; Repetski, AE; McCoy, B; Wells, GA |
| 2018 | Using a meta-narrative literature review and focus groups with key stakeholders to identify perceived challenges and solutions for generating robust evidence on the effectiveness of treatments for rare diseases | Tingley, K; Coyle, D; Graham, ID; Sikora, L; Chakraborty, P; Wilson, K; Mitchell, JJ; Stockler-Ipsiroglu, S; Potter, BK |
| 2018 | Global Estimate of Lung Cancer Mortality Attributable to Residential Radon | Gaskin, J; Coyle, D; Whyte, J; Krewksi, D |
| 2018 | Service Preferences of Parents of Children With Mild Bilateral or Unilateral Hearing Loss: A Conjoint Analysis Study. | Fitzpatrick, EM; Coyle, D; Gaboury, I; Durieux-Smith, A; Whittingham, J; Grandpierre, V; Na, E; Salamatmanesh, M |
| 2018 | Health system costs of potentially inappropriate prescribing in Ontario, Canada: A protocol for a population-based cohort study | Black, CD; Thavorn, K; Coyle, D; Smith, G; Bjerre, LM |
| 2018 | Auditory and language outcomes in children with unilateral hearing loss | Fitzpatrick, EM; Gaboury, I; Durieux-Smith, A; Coyle, D; Whittingham, JA; Nassrallah, F |
| 7-Jan-2019 | A General Population Utility Valuation Study For Metastatic Epidural Spinal Cord Compression Health States. | Pahuta, MA; Wai, EK; Werier, J; van Walraven, C; Coyle, D |
| 30-Jan-2018 | Cost-Effectiveness of Pharmacological Treatments for Osteoporosis Consistent with the Revised Economic Evaluation Guidelines for Canada. | Coyle, D |
| 12-Sep-2018 | Effect of high dose folic acid supplementation in pregnancy on pre-eclampsia (FACT): Double blind, phase III, randomised controlled, international, multicentre trial | Wen, SW; White, RR; Rybak, N; Gaudet, LM; Robson, S; Hague, W; Simms-Stewart, D; Carroli, G; Smith, G; Fraser, WD; Wells, G; Davidge, ST; Kingdom, J; Coyle, D; Fergusson, D; Corsi, DJ; Champagne, J; Sabri, E; Ramsay, T; Mol, BWJ; Oudijk, MA; Walker, MC |
